akre-13f
13F disclosure
akre 13f
reported through filed loaded disclosed holdings 20
Reported allocations
Quarter-end holdings from the manager’s 13F. Weight is calculated from the disclosed equity book; it is not our simulated mirror allocation and it is not a live portfolio.
Unmapped KKR & CO L P DEL 10.13%
Unmapped SOPHIA GENETICS SA 0.30%
No playbook on file for this reported portfolio. The disclosure dates and reported allocations above are the source record.